Comment on

• Outcomes and complications associated with off-label and untested use of drug-eluting stents.

  Beohar N, Davidson CJ, Kip KE, Goodreau L, Vlachos HA, Meyers SN, Benzuly KH, Flaherty JD, Ricciardi MJ, Bennett CL, Williams DO. Beohar N, et al. JAMA. 2007 May 9;297(18):1992-2000. doi: 10.1001/jama.297.18.1992. JAMA. 2007. PMID: 17488964
• Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents.

  Win HK, Caldera AE, Maresh K, Lopez J, Rihal CS, Parikh MA, Granada JF, Marulkar S, Nassif D, Cohen DJ, Kleiman NS; EVENT Registry Investigators. Win HK, et al. JAMA. 2007 May 9;297(18):2001-9. doi: 10.1001/jama.297.18.2001. JAMA. 2007. PMID: 17488965